자가 검사 시장 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 샘플별, 용도별, 유통 채널별, 사용성별, 지역별, 부문별 예측(2025-2030년)

Self-testing Market Growth & Trends:

The global self-testing market size is expected to reach USD 18.32 billion by 2030, registering a CAGR of 8.40% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is owing to the increasing health awareness, convenience, cost-effectiveness, technological advancements, the rising prevalence of chronic diseases, remote healthcare trends, and the need for timely and accessible health information. According to the WHO, noncommunicable diseases cause 41 million deaths every year across the globe.

Moreover, innovations in portable and user-friendly devices, integration with smartphones and digital platforms, enhanced accuracy and sensitivity of testing methods, and the development of rapid diagnostic tools have all contributed to making self-testing more accessible, reliable, and convenient for consumers. For instance, in March 2023, Lucira Health, Inc. announced the launch of the COVID-19 & Flu Home Test. The test is an all-in-one combination test capable of delivering results in 30 minutes. Such advancements are anticipated to expand the market's reach and acceptance over the forecast period.

Furthermore, COVID-19 has accelerated the adoption of self-testing technologies and highlighted the importance of self-diagnostic tools in managing public health crises. Regulatory bodies expedited approvals for various self-testing products to meet the increasing demand, contributing to the market's growth. For instance, in February 2021, Siemens Healthineers received approval from the German Federal Office for Drugs and Medical Devices for its CLINITEST Rapid COVID-19 Antigen Self-Test, enabling its self-administration in Germany.

Key players in the market for self-testing, such as Johnson & Johnson, B. Braun Holding GmbH, Piramal Enterprises, Cardinal Health, and BD, among others, are adopting various strategies to enhance their product penetration and expand their customer base. For instance, in December 2022, Roche Holding partnered with Pfizer on a U.S. campaign. The goal of this campaign is to create awareness regarding COVID-19 treatment and testing.

Self-testing Market Report Highlights:

• Factors boosting the market for self-testing include growing opportunities owing to advancements in technology, increasing R&D activities by leading participants, increasing cases of chronic conditions, and rising adoption of telemedicine
• On the basis of the sample, the blood segment held the largest market share in 2024. The market growth is attributed to growing cases of chronic conditions, and increasing technological advancements in self-testing kits such as AI and ML, which are driving the industry revenue of the segment
• On the basis of products, kits held the largest share and the segment is further projected to expand at the fastest CAGR over the forecast period. The market growth for self-testing is attributed to the growing focus of key players on investing in R&D and developing new products
• On the basis of application, allergy tests held the largest revenue share in 2024. The increasing incidence of allergic conditions is one of the key factors contributing to the growth of the market segment over the forecast period
• On the other hand, the cancer tests segment is projected to showcase the fastest CAGR over the forecast period. Rising cancer cases are one of the key reasons for the segment's growth. The increasing focus of companies to launch new products further boosts segment growth
• On the basis of usage, disposable tests held the dominant revenue share in 2024. The segment is projected to further expand with the fastest CAGR over the forecast period
• North America accounted for the largest revenue share in 2024, which is attributed to the growing cases of chronic conditions that require quick diagnosis, technological advancements in the healthcare sector, and the availability of key players

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Sample Segment
  • 1.2.3. Application Segment
  • 1.2.4. Distribution Channel Segment
  • 1.2.5. Usage Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Global Self-Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of chronic and infectious diseases
    • 3.2.1.2. Advancements in diagnostic technology
    • 3.2.1.3. Growing regulatory approvals
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial costs for advanced kits
    • 3.2.2.2. Limited awareness in emerging markets
• 3.3. Global Self-Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global Self-Testing Market: Sample Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Self-Testing Market Sample Movement Analysis
• 4.3. Global Self-Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million)
• 4.4. Blood
  • 4.4.1. Blood market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5. Urine
  • 4.5.1. Urine market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Stool
  • 4.6.1. Stool market estimates and forecast, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Global Self-Testing Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Self-Testing Market Product Movement Analysis
• 5.3. Global Self-Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 5.4. Kits
  • 5.4.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Devices
  • 5.5.1. Devices market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Strips
  • 5.6.1. Strips market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Self-Testing Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Self-Testing Market Application Movement Analysis
• 6.3. Global Self-Testing Market Size & Trend Analysis, by Application , 2018 to 2030 (USD Million)
• 6.4. Blood Pressure Test
  • 6.4.1. Blood pressure test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Diabetes and Glucose
  • 6.5.1. Diabetes and glucose market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Cholesterol and Triglycerides Tests
  • 6.6.1. Cholesterol and triglycerides tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. Pregnancy Test
  • 6.7.1. Pregnancy test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.8. Diabetes and Glucose
  • 6.8.1. Diabetes and Glucose market estimates and forecast, 2018 - 2030 (USD Million)
• 6.9. STD /STI Test
  • 6.9.1. STD /STI test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.10. Urinary Tract Infection Test
  • 6.10.1. Urinary tract infection test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.11. Cancer Test
  • 6.11.1. Cancer test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.12. Celiac Disease Test
  • 6.5.9.1 Celiac disease test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.13. Thyroid Test
  • 6.13.1. Thyroid test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.14. Transaminase Test
  • 6.14.1. Transaminase test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.15. Anemia Test
  • 6.15.1. Anemia test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.16. Allergy Test
  • 6.16.1. Allergy test market estimates and forecast, 2018 - 2030 (USD Million)
• 6.17. Others
  • 6.17.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Global Self-Testing Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Self-Testing Market Distribution Channel Movement Analysis
  • 7.2.1. Global Self-Testing Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 7.3. Online
  • 7.3.1. Online market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Offline
  • 7.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Self-Testing Market: Usage Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Self-Testing Market Usage Movement Analysis
  • 8.2.1. Global Self-Testing Market Size & Trend Analysis, by usage, 2018 to 2030 (USD Million)
• 8.3. Disposable
  • 8.3.1. Disposable market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Reusable
  • 8.4.1. Reusable market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Self-Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. List of Key Certification Providers/Scheme Owners
• 10.5. Company Profiles/Listing
  • 10.5.1. Geratherm Medical AG
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. Cardinal Health
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. OraSure Technologies, Inc.
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. bioLytical Laboratories Inc.
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. PRIMA Lab SA.
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. BD
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. F. Hoffmann-La Roche Ltd.
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Bionime Corporation
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Abbott
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Everlywell, Inc.
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives